life sciences innovation

From approval to orchestration: where the MHRA is heading

Featured, Insights

From approval to orchestration: where the MHRA is heading

Key points The MHRA's role is shifting [...]

By Dr Ioannis Katsoulis Ben Richardson Dr Dorinda Hickey|2026-09-29T14:31:51+01:0029 September 2026|Featured, Insights|

From access to uptake: Reflections from EMIG’s quarterly meeting

Featured, Insights

From access to uptake: Reflections from EMIG’s quarterly meeting

CF presented at the Ethical Medicines Industry Group quarterly [...]

By Ben Richardson and Ioannis Katsoulis|2026-05-29T10:21:24+01:0027 May 2026|Featured, Insights|

NICE 2026: The goalposts have moved

Featured, Insights

NICE 2026: The goalposts have moved

Three to six months. That is the time saving [...]

By Ben Richardson and Ioannis Katsoulis|2026-04-07T16:01:39+01:001 April 2026|Featured, Insights|

We have turned a corner: What the ARUK conference told us about the future of dementia treatment

Featured, Insights

We have turned a corner: What the ARUK conference told us about the future of dementia treatment

The CF Life Sciences team attended the ARUK 2026 [...]

By Ben Richardson|2026-04-16T12:05:25+01:0025 February 2026|Featured, Insights|

Reflecting on JP Morgan Healthcare Conference 2026: What the strategic shifts mean for delivering innovation to patients

Featured, Insights

Reflecting on JP Morgan Healthcare Conference 2026: What the strategic shifts mean for delivering innovation to patients

As the dust settles from the JP Morgan Healthcare [...]

By Ben Richardson|2026-02-13T16:28:56+00:0013 February 2026|Featured, Insights|

Global Headquarters
London
+ 44 (0) 20 3770 7538
[email protected]

Middle East Office
Riyadh
[email protected]

Sign up for our latest insights

You can unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.